On October 26, 2023, a new indication was added to the instructions for medical use of the Triazavirin drug – now the drug can also be used for the prevention of COVID-19.
Triazavirin is the only direct-acting antiviral drug approved for the prevention of COVID-19 approved by the Ministry of Health of the Russian Federation.